138 related articles for article (PubMed ID: 7517893)
1. Hypoxic coronary vasodilatation and cGMP overproduction are blocked by a nitric oxide synthase inhibitor, but not by a guanylyl cyclase ANF receptor antagonist.
Park KH; Levi R
Eur J Pharmacol; 1994 Apr; 256(1):99-102. PubMed ID: 7517893
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endogenous nitric oxide synthesis activates particulate guanylyl cyclase in the rat renal glomeruli.
Lewko B; Wendt U; Szczepanska-Konkel M; Stepinski J; Drewnowska K; Angielski S
Kidney Int; 1997 Sep; 52(3):654-9. PubMed ID: 9291184
[TBL] [Abstract][Full Text] [Related]
3. Role of nitric oxide in control of prolactin release by the adenohypophysis.
Duvilanski BH; Zambruno C; Seilicovich A; Pisera D; Lasaga M; Diaz MC; Belova N; Rettori V; McCann SM
Proc Natl Acad Sci U S A; 1995 Jan; 92(1):170-4. PubMed ID: 7529411
[TBL] [Abstract][Full Text] [Related]
4. Further attenuation of endothelium-dependent relaxation imparted by natriuretic peptide receptor antagonism.
Wennberg PW; Miller VM; Rabelink T; Burnett JC
Am J Physiol; 1999 Oct; 277(4):H1618-21. PubMed ID: 10516202
[TBL] [Abstract][Full Text] [Related]
5. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries.
Chan CK; Mak J; Gao Y; Man RY; Vanhoutte PM
Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2313-21. PubMed ID: 21984543
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide is a mediator of hypoxic coronary vasodilatation. Relation to adenosine and cyclooxygenase-derived metabolites.
Park KH; Rubin LE; Gross SS; Levi R
Circ Res; 1992 Oct; 71(4):992-1001. PubMed ID: 1325300
[TBL] [Abstract][Full Text] [Related]
8. Glutathione causes coronary vasodilation via a nitric oxide- and soluble guanylate cyclase-dependent mechanism.
Cheung PY; Schulz R
Am J Physiol; 1997 Sep; 273(3 Pt 2):H1231-8. PubMed ID: 9321811
[TBL] [Abstract][Full Text] [Related]
9. Increase in nitric oxide and cyclic GMP of rat cerebellum by radio frequency burst-type electromagnetic field radiation.
Miura M; Takayama K; Okada J
J Physiol; 1993 Feb; 461():513-24. PubMed ID: 7688808
[TBL] [Abstract][Full Text] [Related]
10. Hypoxic vasodilatation in isolated, perfused guinea-pig heart: an analysis of the underlying mechanisms.
von Beckerath N; Cyrys S; Dischner A; Daut J
J Physiol; 1991 Oct; 442():297-319. PubMed ID: 1798031
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation.
Leitch IM; Read MA; Boura AL; Walters WA
Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152
[TBL] [Abstract][Full Text] [Related]
12. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase.
Arnal JF; Warin L; Michel JB
J Clin Invest; 1992 Aug; 90(2):647-52. PubMed ID: 1379615
[TBL] [Abstract][Full Text] [Related]
13. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature.
Brunner F; Wölkart G
Cardiovasc Res; 2001 Aug; 51(3):577-84. PubMed ID: 11476748
[TBL] [Abstract][Full Text] [Related]
14. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
Imura R; Sano T; Goto J; Yamada K; Matsuda Y
Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
[TBL] [Abstract][Full Text] [Related]
16. C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems.
Wright RS; Wei CM; Kim CH; Kinoshita M; Matsuda Y; Aarhus LL; Burnett JC; Miller WL
J Am Coll Cardiol; 1996 Oct; 28(4):1031-8. PubMed ID: 8837586
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic factor activates membrane-bound guanylate cyclase of chief cells.
Cherner JA; Singh G; Naik L
Life Sci; 1990; 47(7):669-77. PubMed ID: 1976196
[TBL] [Abstract][Full Text] [Related]
18. Opioids and nitric oxide contribute to hypoxia-induced pial arterial vasodilation in newborn pigs.
Armstead WM
Am J Physiol; 1995 Jan; 268(1 Pt 2):H226-32. PubMed ID: 7530918
[TBL] [Abstract][Full Text] [Related]
19. Cyclic GMP release and vasodilatation induced by EDRF and atrial natriuretic factor in the isolated perfused kidney of the rat.
Burton GA; MacNeil S; de Jonge A; Haylor J
Br J Pharmacol; 1990 Feb; 99(2):364-8. PubMed ID: 2158376
[TBL] [Abstract][Full Text] [Related]
20. New signaling mechanism of angiotensin II in neuroblastoma neuro-2A cells: activation of soluble guanylyl cyclase via nitric oxide synthesis.
Chaki S; Inagami T
Mol Pharmacol; 1993 Apr; 43(4):603-8. PubMed ID: 7682650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
